The role of Interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
Chih‐Sung Liang(Tri-Service General Hospital), Fu‐Chi Yang(Tri-Service General Hospital), Kuan‐Pin Su(China Medical University), Chia‐Kuang Tsai(National Defense University), Ta‐Chuan Yeh(Tri-Service General Hospital), Ming‐Wei Su(Institute of Biomedical Sciences, Academia Sinica), Hsuan‐Te Chu(Tri-Service General Hospital), Yu‐Kai Lin(Tri-Service General Hospital), Guan‐Yu Lin(Tri-Service General Hospital), Jiunn‐Tay Lee(Tri-Service General Hospital), Chia‐Lin Tsai(Tri-Service General Hospital), Che‐Sheng Chu(Kaohsiung Medical University)
Cited by 0
Related Papers
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Relationship between depression and frailty in older adults: A systematic review and meta-analysis
|Ageing Research Reviews|2017|881
Diet and depression: exploring the biological mechanisms of action
|Molecular Psychiatry|2020|634
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries
|Molecular Psychiatry|2022|218
Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis
|The Lancet Healthy Longevity|2021|212